FDA Inspection 767444 — Adare Pharmaceuticals, Inc.

Adare Pharmaceuticals, Inc. — FEI 1525864

The FDA completed an inspection of Adare Pharmaceuticals, Inc. on Dec 21, 2011 in Vandalia, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 21, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vandalia, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.